The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Large Animals Drugs Market Research Report 2024
Synopsis
The global Large Animals Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
This report aims to provide a comprehensive presentation of the global market for Large Animals Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Animals Drugs.
Report Scope
The Large Animals Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Animals Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Animals Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Segment by Type
Molecular Diagnostics
Immunodiagnostics
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Large Animals Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Large Animals Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 25%.
This report aims to provide a comprehensive presentation of the global market for Large Animals Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Animals Drugs.
Report Scope
The Large Animals Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Large Animals Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Animals Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
IDEXX Laboratories
Elanco Animal Health
Bayer Animal Health
Merck Animal Health
Dechra Veterinary Products
Parnell
Abaxis
Virbac
Ceva
Meiji
Vetoquinol
Ouro Fino Saude
Animalcare Group
IDvet
Shenzhen Mindray Bio-Medical
Bio-Rad Laboratories
Segment by Type
Molecular Diagnostics
Immunodiagnostics
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Large Animals Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Large Animals Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Diagnostics
1.2.3 Immunodiagnostics
1.3 Market by Application
1.3.1 Global Large Animals Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Large Animals Drugs Market Perspective (2019-2030)
2.2 Large Animals Drugs Growth Trends by Region
2.2.1 Global Large Animals Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Large Animals Drugs Historic Market Size by Region (2019-2024)
2.2.3 Large Animals Drugs Forecasted Market Size by Region (2025-2030)
2.3 Large Animals Drugs Market Dynamics
2.3.1 Large Animals Drugs Industry Trends
2.3.2 Large Animals Drugs Market Drivers
2.3.3 Large Animals Drugs Market Challenges
2.3.4 Large Animals Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Large Animals Drugs Players by Revenue
3.1.1 Global Top Large Animals Drugs Players by Revenue (2019-2024)
3.1.2 Global Large Animals Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Large Animals Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Large Animals Drugs Revenue
3.4 Global Large Animals Drugs Market Concentration Ratio
3.4.1 Global Large Animals Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Large Animals Drugs Revenue in 2023
3.5 Large Animals Drugs Key Players Head office and Area Served
3.6 Key Players Large Animals Drugs Product Solution and Service
3.7 Date of Enter into Large Animals Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Large Animals Drugs Breakdown Data by Type
4.1 Global Large Animals Drugs Historic Market Size by Type (2019-2024)
4.2 Global Large Animals Drugs Forecasted Market Size by Type (2025-2030)
5 Large Animals Drugs Breakdown Data by Application
5.1 Global Large Animals Drugs Historic Market Size by Application (2019-2024)
5.2 Global Large Animals Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Large Animals Drugs Market Size (2019-2030)
6.2 North America Large Animals Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Large Animals Drugs Market Size by Country (2019-2024)
6.4 North America Large Animals Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Large Animals Drugs Market Size (2019-2030)
7.2 Europe Large Animals Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Large Animals Drugs Market Size by Country (2019-2024)
7.4 Europe Large Animals Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Large Animals Drugs Market Size (2019-2030)
8.2 Asia-Pacific Large Animals Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Large Animals Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Large Animals Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Large Animals Drugs Market Size (2019-2030)
9.2 Latin America Large Animals Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Large Animals Drugs Market Size by Country (2019-2024)
9.4 Latin America Large Animals Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Large Animals Drugs Market Size (2019-2030)
10.2 Middle East & Africa Large Animals Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Large Animals Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Large Animals Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Large Animals Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Large Animals Drugs Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Large Animals Drugs Introduction
11.2.4 Zoetis Revenue in Large Animals Drugs Business (2019-2024)
11.2.5 Zoetis Recent Development
11.3 IDEXX Laboratories
11.3.1 IDEXX Laboratories Company Detail
11.3.2 IDEXX Laboratories Business Overview
11.3.3 IDEXX Laboratories Large Animals Drugs Introduction
11.3.4 IDEXX Laboratories Revenue in Large Animals Drugs Business (2019-2024)
11.3.5 IDEXX Laboratories Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Detail
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Large Animals Drugs Introduction
11.4.4 Elanco Animal Health Revenue in Large Animals Drugs Business (2019-2024)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Detail
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Large Animals Drugs Introduction
11.5.4 Bayer Animal Health Revenue in Large Animals Drugs Business (2019-2024)
11.5.5 Bayer Animal Health Recent Development
11.6 Merck Animal Health
11.6.1 Merck Animal Health Company Detail
11.6.2 Merck Animal Health Business Overview
11.6.3 Merck Animal Health Large Animals Drugs Introduction
11.6.4 Merck Animal Health Revenue in Large Animals Drugs Business (2019-2024)
11.6.5 Merck Animal Health Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Detail
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Large Animals Drugs Introduction
11.7.4 Dechra Veterinary Products Revenue in Large Animals Drugs Business (2019-2024)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Parnell
11.8.1 Parnell Company Detail
11.8.2 Parnell Business Overview
11.8.3 Parnell Large Animals Drugs Introduction
11.8.4 Parnell Revenue in Large Animals Drugs Business (2019-2024)
11.8.5 Parnell Recent Development
11.9 Abaxis
11.9.1 Abaxis Company Detail
11.9.2 Abaxis Business Overview
11.9.3 Abaxis Large Animals Drugs Introduction
11.9.4 Abaxis Revenue in Large Animals Drugs Business (2019-2024)
11.9.5 Abaxis Recent Development
11.10 Virbac
11.10.1 Virbac Company Detail
11.10.2 Virbac Business Overview
11.10.3 Virbac Large Animals Drugs Introduction
11.10.4 Virbac Revenue in Large Animals Drugs Business (2019-2024)
11.10.5 Virbac Recent Development
11.11 Ceva
11.11.1 Ceva Company Detail
11.11.2 Ceva Business Overview
11.11.3 Ceva Large Animals Drugs Introduction
11.11.4 Ceva Revenue in Large Animals Drugs Business (2019-2024)
11.11.5 Ceva Recent Development
11.12 Meiji
11.12.1 Meiji Company Detail
11.12.2 Meiji Business Overview
11.12.3 Meiji Large Animals Drugs Introduction
11.12.4 Meiji Revenue in Large Animals Drugs Business (2019-2024)
11.12.5 Meiji Recent Development
11.13 Vetoquinol
11.13.1 Vetoquinol Company Detail
11.13.2 Vetoquinol Business Overview
11.13.3 Vetoquinol Large Animals Drugs Introduction
11.13.4 Vetoquinol Revenue in Large Animals Drugs Business (2019-2024)
11.13.5 Vetoquinol Recent Development
11.14 Ouro Fino Saude
11.14.1 Ouro Fino Saude Company Detail
11.14.2 Ouro Fino Saude Business Overview
11.14.3 Ouro Fino Saude Large Animals Drugs Introduction
11.14.4 Ouro Fino Saude Revenue in Large Animals Drugs Business (2019-2024)
11.14.5 Ouro Fino Saude Recent Development
11.15 Animalcare Group
11.15.1 Animalcare Group Company Detail
11.15.2 Animalcare Group Business Overview
11.15.3 Animalcare Group Large Animals Drugs Introduction
11.15.4 Animalcare Group Revenue in Large Animals Drugs Business (2019-2024)
11.15.5 Animalcare Group Recent Development
11.16 IDvet
11.16.1 IDvet Company Detail
11.16.2 IDvet Business Overview
11.16.3 IDvet Large Animals Drugs Introduction
11.16.4 IDvet Revenue in Large Animals Drugs Business (2019-2024)
11.16.5 IDvet Recent Development
11.17 Shenzhen Mindray Bio-Medical
11.17.1 Shenzhen Mindray Bio-Medical Company Detail
11.17.2 Shenzhen Mindray Bio-Medical Business Overview
11.17.3 Shenzhen Mindray Bio-Medical Large Animals Drugs Introduction
11.17.4 Shenzhen Mindray Bio-Medical Revenue in Large Animals Drugs Business (2019-2024)
11.17.5 Shenzhen Mindray Bio-Medical Recent Development
11.18 Bio-Rad Laboratories
11.18.1 Bio-Rad Laboratories Company Detail
11.18.2 Bio-Rad Laboratories Business Overview
11.18.3 Bio-Rad Laboratories Large Animals Drugs Introduction
11.18.4 Bio-Rad Laboratories Revenue in Large Animals Drugs Business (2019-2024)
11.18.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
